[Human proinsulin-C-peptide radioimmunoassay method; stability of the assay kit]. 1977

N Nakazawa, and K Maki, and H Ogawa, and O Ikeda

We have been studies time sequent stability each on standard human-C-peptide, human-C-peptide antiserum, 125I-tyrosyl human-C-peptide and the assay kit (all reagent) which is necessary in human proinsulin-C-peptide radioimmunoassay(RIA). Also we measured using this assay system, human proinsulin C-peptide in blood after oral administration of glucose to normal subject. Standard human-C-peptide and human-C-peptide antiserum were very stable on storage at 4 degrees C, 125I-tyrosyl human-C-peptide was unstable as compared with the former two, The stability of the assay kit was influenced by the stability of 125I-tyrosyl human-C-peptide, and was stable at 4 degrees C for ten weeks after preparation. Three lots of the assay kit prepared at different period showed almost same stability. We think this assay system using the assay kit is satisfactory in respect of stability. The measured values of human proinsulin-C-peptide in blood, using this assay system, showed insulin secretory reaction after oral administration of glucose.

UI MeSH Term Description Entries
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002096 C-Peptide The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin. Proinsulin C-Peptide,C-Peptide, Proinsulin,Connecting Peptide,C Peptide,C Peptide, Proinsulin,Proinsulin C Peptide
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

N Nakazawa, and K Maki, and H Ogawa, and O Ikeda
April 1974, Endocrinologia japonica,
N Nakazawa, and K Maki, and H Ogawa, and O Ikeda
April 1973, Endocrinologia japonica,
N Nakazawa, and K Maki, and H Ogawa, and O Ikeda
November 1980, Horumon to rinsho. Clinical endocrinology,
N Nakazawa, and K Maki, and H Ogawa, and O Ikeda
January 1995, Biochemistry and molecular biology international,
N Nakazawa, and K Maki, and H Ogawa, and O Ikeda
November 1975, Rinsho byori. The Japanese journal of clinical pathology,
N Nakazawa, and K Maki, and H Ogawa, and O Ikeda
November 1989, Radioisotopes,
N Nakazawa, and K Maki, and H Ogawa, and O Ikeda
August 1974, Kaku igaku. The Japanese journal of nuclear medicine,
N Nakazawa, and K Maki, and H Ogawa, and O Ikeda
August 2005, The FEBS journal,
N Nakazawa, and K Maki, and H Ogawa, and O Ikeda
May 1986, Clinical chemistry,
N Nakazawa, and K Maki, and H Ogawa, and O Ikeda
September 1970, Acta diabetologica latina,
Copied contents to your clipboard!